There were no between-groups differences in serum markers of myostatin-pathway activity ( P > @ ) , but subjects in the RWR condition experienced a significant increase in serum myostatin ( P < @ ) , a decrease in follistatin ( P < @ ) , and an increase in myostatin-to-follistatin ratio ( P < @ ) .